These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8314014)
1. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Aguilar-Diosdado M; Parkinson D; Corbett JA; Kwon G; Marshall CA; Gingerich RL; Santiago JV; McDaniel ML Diabetes; 1994 Mar; 43(3):418-25. PubMed ID: 8314014 [TBL] [Abstract][Full Text] [Related]
2. Glutamic acid decarboxylase and other autoantigens in IDDM. Nepom GT Curr Opin Immunol; 1995 Dec; 7(6):825-30. PubMed ID: 8679127 [TBL] [Abstract][Full Text] [Related]
4. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648 [TBL] [Abstract][Full Text] [Related]
5. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes. Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314 [TBL] [Abstract][Full Text] [Related]
6. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific. Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429 [TBL] [Abstract][Full Text] [Related]
7. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. Richter W; Endl J; Eiermann TH; Brandt M; Kientsch-Engel R; Thivolet C; Jungfer H; Scherbaum WA Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8467-71. PubMed ID: 1382289 [TBL] [Abstract][Full Text] [Related]
8. Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. Christie MR; Hollands JA; Brown TJ; Michelsen BK; Delovitch TL J Clin Invest; 1993 Jul; 92(1):240-8. PubMed ID: 8325989 [TBL] [Abstract][Full Text] [Related]
9. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Roep BO Diabetes; 1996 Sep; 45(9):1147-56. PubMed ID: 8772714 [TBL] [Abstract][Full Text] [Related]
10. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
11. Glucose regulation of the autoantigen GAD65 in human pancreatic islets. Björk E; Kämpe O; Karlsson FA; Pipeleers DG; Andersson A; Hellerström C; Eizirik DL J Clin Endocrinol Metab; 1992 Dec; 75(6):1574-6. PubMed ID: 1464667 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039 [TBL] [Abstract][Full Text] [Related]
13. T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diaz JL; Ways J; Hammonds P Diabetes; 1992 Jan; 41(1):118-21. PubMed ID: 1727731 [TBL] [Abstract][Full Text] [Related]
14. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Myers MA; Rabin DU; Rowley MJ Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [TBL] [Abstract][Full Text] [Related]
18. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129 [TBL] [Abstract][Full Text] [Related]
19. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Karlsen AE; Hagopian WA; Petersen JS; Boel E; Dyrberg T; Grubin CE; Michelsen BK; Madsen OD; Lernmark A Diabetes; 1992 Oct; 41(10):1355-9. PubMed ID: 1397711 [TBL] [Abstract][Full Text] [Related]